For GLP-1 medications, data was only available for a year after the drugs were stopped, with the overall projections based on follow-ups up to 52 weeks
If you experience symptoms like headache, drowsiness, weakness, dizziness, feeling hungry, confusion, irritability, rapid heartbeat, or sweating, inform your doctor immediately
Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach, PubMed [accessed 25 February 2026] Heartburn and acid reflux, NHS [accessed 25 February 2026] Mechanisms of cancer resistance in long-lived mammals, PubMed [accessed 25 February 2026]
Why this study matters: SURMOUNT-MAINTAIN randomized adults after 60 weeks of tirzepatide to continue maximum dose, reduce to 5 mg, or switch to placebo for 52 weeks